PALO ALTO, Calif. and TORONTO – Inpixon (Nasdaq: INPX), a leading indoor data company that specializes in delivering indoor intelligence, today announced that it is offering certain of its location-based technology applications and services without cost or at reduced rates (depending on the solution) to healthcare providers and other organizations that are seeking solutions to assist in controlling the spread of COVID-19 or in managing the impact of the pandemic to ensure the safety and well-being of citizens.
Inpixon’s indoor intelligence solutions can equip hospitals and other indoor spaces with a means to create situational awareness and visibility into the movement of people and equipment, identifying potential risk. The company’s technology, which consists of indoor maps, positioning tags and sensors, and analytics, can help address several critical use cases including the following:
“This pandemic has swept the globe, disrupting our lives in nearly every way. It is a tragedy of immense proportion, and with so many unknowns, we want to help provide indoor spaces with the tools and technology needed to enhance visibility, manage scarce resources, and reduce unnecessary exposure,” commented Inpixon’s CEO, Nadir Ali. “Organizations will need to be prepared with solutions to assist them in managing and controlling the impact of this virus over the next 12 to 18 months. Our technology can help to provide a level of certainty in uncertain times. Whether that means diminishing the risk of infected parties coming into contact with others or contact tracing to identify the movement of an infection threat, Inpixon can power multiple location-based use cases and provide invaluable intelligence. Our team is sensitive to the fact that many of the affected organizations who could benefit from our solutions are currently inundated responding to day-to-day demands. When the time is right, we encourage affected organizations that believe they could benefit from the company’s indoor intelligence technology to reach out. We are immensely grateful to those on the front lines of this pandemic and have personnel standing by to assist in offering solutions when needed.”
Government public health experts are seeking the support of technology companies to examine the ways in which location data can help in this time of crisis. Location technology plays a pivotal role in the fight against pandemics, and Inpixon urges organizations to take action and explore how to safeguard the public’s well-being. In the face of a global disruption such as what we are seeing with the COVID-19 coronavirus, we need to consider all the ways technology and innovation can equip us with tools to save lives.
For any healthcare providers or other organizations that are interested in finding out more information, please contact Inpixon to assess your situation and needs.
About Inpixon
Inpixon® (Nasdaq: INPX) is an indoor intelligence company that specializes in capturing, interpreting and giving context to indoor data so it can be translated into actionable intelligence. The company’s indoor location and data platform ingests diverse data from IoT, third-party and proprietary sensors designed to detect and position all active cellular, Wi-Fi, UWB and Bluetooth devices, and uses a proprietary process that ensures anonymity. Paired with a high-performance data analytics engine, patented algorithms, and advanced mapping technology, Inpixon’s solutions are leveraged by a multitude of industries to do good with indoor data. This multidisciplinary depiction of indoor data enables users to increase revenue, decrease costs, and enhance safety. Inpixon customers can boldly take advantage of location awareness, analytics, sensor fusion and the Internet of Things (IoT) to uncover the untold stories of the indoors. For the latest insights, follow Inpixon on LinkedIn, Twitter, and visit inpixon.com.
Safe Harbor Statement
All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of Inpixon and its subsidiaries, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of economic conditions, the performance of management and employees, Inpixon’s ability to maintain compliance with Nasdaq’s minimum bid price requirement and other continued listing requirements, including during a panel monitoring period ending on February 5, 2021, the ability to obtain financing, competition, general economic conditions and other factors that are detailed in Inpixon’s periodic and current reports available for review at sec.gov. Furthermore, Inpixon operates in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. Inpixon disclaims any intention to, and undertakes no obligation to, update or revise forward-looking statements.
